MYP_162933
Basic Information
Trastuzumab
Anticancer
Immunology Immunomodulation Immunotherapy
Standard
224 amino acids
C1072H1668N288O351S6
Standard
Sequence
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECEVQLVESGGG
Physicochemical Analysis
24398.82 Da
6.35
-1.01
-1.50
-0.0045
-0.43
0.58
-0.01
54.41
66.12
0.0938
25900.00
26150.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0319576 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; Cricetulus griseus [Animal]
Monoclonal antibody
9606;10029
Structure & Mods
linear multidomain protein biologic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anticancer Immunotherapy Monoclonal antibody
average 28.5 d